MiR-34c inhibits osteosarcoma metastasis and chemoresistance. - Wikidata - wikimedia - TriplyDB

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

http://www.wikidata.org/entity/Q38997836

about

MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells MicroRNAs as potential biomarkers in cancer: opportunities and challenges Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.Mechanisms of doxorubicin resistance in hepatocellular carcinoma MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Genetic factors conferring metastasis in osteosarcoma.A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.Noncoding RNA in drug resistant sarcoma.Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.A novel circulating hsa_circ_0081001 act as a potential biomarker for diagnosis and prognosis of osteosarcoma

P2860

Q28551027-073032D1-1636-405A-9E91-62B77016CFF0 Q35271157-B6815936-F279-404A-9EA7-44FDCFA4D560 Q36288519-A745BA8C-B362-40B5-97EF-0CD9FD1E9B0B Q36687760-71D395BF-3C26-476C-A5F6-85C817C549C1 Q36944910-DB3ABACB-A8EF-45B1-AE85-DE5569316320 Q38546133-3E94714B-C8A4-4D96-8144-30F865369A48 Q38806986-452E0DAA-CB60-43D1-92A8-2464C6AA8FC6 Q38832378-A2059246-3235-4902-A075-05C001A7910D Q41347495-689468C6-A0BB-4BBE-920F-B27BAEFB23A2 Q41924654-16EC3DB3-9676-4C81-B14A-99AB9AAECB2A Q47132356-24F08DD7-5E08-4D49-AD2F-821623251659 Q49967917-B306F26E-CC70-4FF2-90FD-EF3A6C402336 Q52645998-E54EEA85-5497-437D-9FFF-A30FA7C98EE2 Q58773880-CE628DE6-197F-4C48-A2F3-690B56128935

P2860

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

http://www.wikidata.org/entity/Q38997836

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

@en

type

label

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

@en

prefLabel

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

@en

P1433

Q38997836-E12C75FB-211E-4769-AE72-D66D2512909B

P1476

Q38997836-7C259442-8BA6-4F02-9510-38657262FA54

P2093

Q38997836-1F8957DE-D307-4A95-9028-771891E89741

Q38997836-4EE1F733-7FF3-4254-B122-8F1756428FFD

Q38997836-7EE61BCA-3B7B-49B8-A6B9-EDAA24635423

Q38997836-80D55AB5-B05C-4F48-ADF2-66CE57AE21B9

Q38997836-BBE74EA4-0885-4FC3-8264-0B5862FD37AD

P2860

Q38997836-07283573-EF0A-431B-AB15-B182135F7587

Q38997836-076EA8F1-3701-4E43-8A30-73BBFAB636DC

Q38997836-0B92F817-D6A5-45A6-AD5A-65854726FC98

Q38997836-1837371E-8B87-4588-AA3B-E9F9942855FF

Q38997836-2B4E8903-8D34-463D-A3F0-868E2092AB5C

Q38997836-2EFFB200-0C87-4C06-BD6B-D109E2D850C2

Q38997836-3E20704B-AED7-4936-8D9E-EAFDD6753192

Q38997836-477EECCD-EA8E-4F09-839F-E7FFA701D224

Q38997836-5B4599F2-7496-4780-9006-AC4D218B69A5

Q38997836-6139A833-C7C4-4A76-B94C-FD3C93E35159

P2888

Q38997836-5A3BB866-920E-4D51-A344-46FDED5C797E

P304

Q38997836-D52C9273-C2AD-4CEB-BB38-A1F17FD4C6E8

P31

Q38997836-8FAF296E-ECC6-4C9F-BC31-D7B38B734F85

P356

Q38997836-DC549C2D-E150-4718-9E2E-3A6849A02F7A

P433

Q38997836-1E1A0D78-6AB1-4638-92D1-35D8F95BEE0F

P478

Q38997836-DDA9C090-3170-4419-A394-43676C7ADB61

P577

Q38997836-0DBBF41F-15F8-4E08-9EC0-78226453BE75

P6179

Q38997836-9E9185D8-B137-4E92-B8EC-F47F337FEE9E

P698

Q38997836-DC0C97A8-BC7A-40F9-B302-42681DFEE7EB

P356

S12032-014-0972-X

P1433

Medical Oncology

P1476

MiR-34c inhibits osteosarcoma metastasis and chemoresistance.

@en

P2093

Cheng-Xiong Xu

http://www.w3.org/2001/XMLSchema#string

Hua Jin

http://www.w3.org/2001/XMLSchema#string

Meng Xu

http://www.w3.org/2001/XMLSchema#string

Wen-Zhi Bi

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis

MicroRNAs: genomics, biogenesis, mechanism, and function

Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

The molecular pathogenesis of osteosarcoma: a review

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

SomamiR: a database for somatic mutations impacting microRNA function in cancer.

MicroRNA expression and function in cancer.

P2888

s12032-014-0972-x

P304

972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0972-X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037403926

http://www.w3.org/2001/XMLSchema#string

P698

24802328

http://www.w3.org/2001/XMLSchema#string